Anaerobic Coverage with Cephalosporins
Introduction to Anaerobic Coverage
- Most cephalosporins have poor activity against anaerobes, particularly B. fragilis, and susceptibility profiles for B. fragilis group isolates demonstrate substantial resistance to cefotetan and cefoxitin, making them unreliable for monotherapy against B. fragilis 1
- The Infectious Diseases Society of America (IDSA) guidelines recommend combining cephalosporins with metronidazole for adequate anaerobic coverage, particularly against B. fragilis 1
Recommended Treatment Regimens
- For infections where B. fragilis is suspected, the IDSA guidelines recommend first/second-generation cephalosporins (cefazolin or cefuroxime) plus metronidazole for mild-to-moderate infections 1
- For high-severity infections where B. fragilis is suspected, the IDSA guidelines recommend third/fourth-generation cephalosporins (cefotaxime, ceftriaxone, ceftizoxime, ceftazidime, cefepime) plus metronidazole 1
- For community-acquired intra-abdominal infections where B. fragilis is common, the IDSA guidelines recommend cefazolin or cefuroxime plus metronidazole for mild-to-moderate infections, and a third/fourth-generation cephalosporin plus metronidazole for severe infections 1
Alternative Agents with Inherent Anaerobic Activity
- Beta-lactam/beta-lactamase inhibitors (ampicillin/sulbactam, piperacillin/tazobactam) and carbapenems (ertapenem, imipenem/cilastatin, meropenem) have inherent activity against B. fragilis and do not require combination with metronidazole 1
- Newer cephalosporin/beta-lactamase inhibitor combinations (ceftolozane/tazobactam, ceftazidime/avibactam) should be combined with metronidazole for complicated intra-abdominal infections due to limited activity against some Bacteroides species, as recommended by the World Society of Emergency Surgery (WSES) guidelines 2
Resistance and Treatment Considerations
- B. fragilis resistance to cefoxitin and cefotetan has increased over time, making them unreliable as monotherapy 1
- The WSES guidelines discourage extended use of cephalosporins due to selection pressure resulting in resistance emergence 2
- When treating infections where B. fragilis is a concern, it is recommended to always add metronidazole when using standard cephalosporins, consider alternative single agents with inherent anaerobic activity for severe infections, and monitor local resistance patterns 1